Try our beta test site
228 studies found for:    "Anaplastic oligodendroglioma"
Show Display Options
Rank Status Study
21 Unknown  Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine(BCNU);   Procedure: Surgery
22 Recruiting Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Glioma;   Recurrent Glioblastoma
Interventions: Biological: Carcinoembryonic Antigen-Expressing Measles Virus;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
23 Active, not recruiting Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
24 Active, not recruiting Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
25 Terminated Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma
Intervention: Drug: Talampanel
26 Active, not recruiting
Has Results
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Adult Anaplastic Oligodendroglioma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Recurrent Adult Brain Neoplasm
Interventions: Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
27 Completed Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Gliomas;   Glioblastoma Multiforme;   Recurrent Brain Tumor
Interventions: Drug: carmustine;   Drug: mercaptopurine;   Drug: streptozocin
28 Active, not recruiting Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Conditions: Brain Tumor, Recurrent;   Glioblastoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Glioma
Interventions: Procedure: Cytoreductive surgery;   Drug: Perifosine;   Drug: Temsirolimus
29 Withdrawn Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Glioma
Intervention: Drug: enzyme-inducing anti-epileptic drugs
30 Completed Sorafenib in Newly Diagnosed High Grade Glioma
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma
Intervention: Drug: Sorafenib dose escalation
31 Terminated Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma;   Gliosarcoma
Interventions: Dietary Supplement: ascorbic acid;   Drug: temozolomide;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
32 Completed AZD8055 for Adults With Recurrent Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Malignant Glioma;   Brainstem Glioma
Intervention: Drug: AZD8055
33 Completed
Has Results
BIBF 1120 for Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Drug: BIBF 1120
34 Terminated (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
Conditions: Low Grade Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Oligoastrocytoma
Intervention:
35 Completed
Has Results
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
Conditions: Glioblastoma Multiforme;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma
Interventions: Drug: ZD6474 (Vandetanib);   Drug: Carboplatin
36 Completed
Has Results
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma
Interventions: Biological: Bevacizumab;   Drug: MLN-518 (Tandutinib);   Procedure: Quality-of-life assessment
37 Completed Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
38 Withdrawn Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors
Conditions: Malignant Intracranial Tumors;   Glioblastoma Multiforme;   Anaplastic Astrocytomas;   Anaplastic Oligodendrogliomas;   Anaplastic Ependymoma
Intervention: Procedure: Photodynamic therapy using Photosan and LumaCare™ Lamp Model LC-122M
39 Completed
Has Results
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: ziv-aflibercept;   Other: pharmacological study;   Other: laboratory biomarker analysis
40 Completed Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: sorafenib tosylate;   Other: pharmacological study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.